Goldline Pharmac

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1CLW01015
  • NSEID:
  • BSEID: 544759
INR
46.14
2.19 (4.98%)
BSENSE

May 27

BSE+NSE Vol: 363000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is -0.90% vs 2.77% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 11.39% vs 16.18% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is -15.00% vs 36.00% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 33.33% vs -57.14% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 19.74% vs 15.93% in Mar 2024

Compare Balance Sheet Results of Goldline Pharmac
Markets Mojo
Figures in Cr
Standalone - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
8.71
12.31
-3.60
-29.24%
Share Warrants & Outstandings
Total Reserve
1.65
33.10
-31.45
-95.02%
Shareholder's Funds
10.35
45.42
-35.07
-77.21%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
5.38
2.38
3.00
126.05%
Secured Loans
1.02
2.38
-1.36
-57.14%
Unsecured Loans
4.37
0.00
4.37
0.00%
Deferred Tax Assets / Liabilities
0.09
-4.37
4.46
102.06%
Other Long Term Liabilities
0.88
0.00
0.88
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.12
-0.12
-100.00%
Total Non-Current Liabilities
4.16
-1.87
6.03
322.46%
Current Liabilities
Trade Payables
2.06
5.59
-3.53
-63.15%
Other Current Liabilities
1.87
1.74
0.13
7.47%
Short Term Borrowings
7.84
5.02
2.82
56.18%
Short Term Provisions
0.00
0.01
-0.01
-100.00%
Total Current Liabilities
11.77
12.37
-0.60
-4.85%
Total Liabilities
26.28
55.92
-29.64
-53.00%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
3.71
27.18
-23.47
-86.35%
Less: Accumulated Depreciation
0.82
8.48
-7.66
-90.33%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.89
18.70
-15.81
-84.55%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
10.14
-10.14
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.04
0.05
-0.01
-20.00%
Long Term Loans & Advances
0.00
2.12
-2.12
-100.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
2.93
31.01
-28.08
-90.55%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.78
8.22
-1.44
-17.52%
Sundry Debtors
10.69
13.54
-2.85
-21.05%
Cash and Bank
1.24
0.73
0.51
69.86%
Other Current Assets
0.52
0.41
0.11
26.83%
Short Term Loans and Advances
4.12
2.00
2.12
106.00%
Total Current Assets
23.35
24.91
-1.56
-6.26%
Net Current Assets (Including Current Investments)
11.58
12.54
-0.96
-7.66%
Total Current Assets Excluding Current Investments
23.35
24.91
-1.56
-6.26%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
26.28
55.92
-29.64
-53.00%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
8.84
7.40
1.44
19.46%
Book Value per share (adjusted)
12.39
7.38
5.01
67.89%
Annual - Borrowings
Borrowings 11.03 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -0.90% vs 2.77% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.88 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 11.39% vs 16.18% in Mar 2024

Annual - Fixed Assets
Fixed Assets 2.89 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -15.00% vs 36.00% in Mar 2024

Annual - Investments
Investments 0.04 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 33.33% vs -57.14% in Mar 2024

Annual - Current Assets
Current Assets 23.35 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 19.74% vs 15.93% in Mar 2024